Quarterly report [Sections 13 or 15(d)]

CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net (decrease) increase in net assets from operations $ (367,469) $ 841,447
Adjustments to reconcile net (decrease) increase in net assets to net cash (used in) provided by operating activities:    
Investments in portfolio companies (5,127,924) (375,000)
Proceeds from sale of portfolio investments 1,319,571 955,357
Proceeds from loan repayments 29,170 8,369,876
Net realized gain on sales and dispositions of portfolio investments (1,075,571) (925,332)
Change in unrealized appreciation/depreciation on investments 2,040,116 1,298,384
Deferred income tax benefit 0 (2,725)
Amortization 6,250 6,250
Original issue discount amortization (3,600) (23,502)
Non-cash conversion of debenture interest (244,330) (624,105)
Non-cash conversion of loan modification fee 0 (15,000)
Change in interest receivable allowance 0 25,337
Changes in operating assets and liabilities:    
(Increase) decrease in interest receivable (76,923) 108,920
Increase in other assets (25,866) (54,121)
Increase in prepaid income taxes (38,605) (9,872)
Decrease in accounts payable and accrued expenses (2,102) (46,892)
Increase (decrease) in due to investment adviser 13,304 (1,637,008)
Decrease in capital gains incentive fees payable 0 (75,000)
Increase (decrease) in deferred revenue 36,710 (87,778)
Total adjustments (3,149,800) 6,887,789
Net cash (used in) provided by operating activities (3,517,269) 7,729,236
Cash flows from financing activities:    
Net proceeds from (repayment of) line of credit 500,000 (600,000)
Payment of cash dividend (861,129) (3,030,772)
Net cash used in financing activities (361,129) (3,630,772)
Net (decrease) increase in cash and cash equivalents (3,878,398) 4,098,464
Cash and cash equivalents:    
Beginning of period 4,208,948 834,805
End of period $ 330,550 $ 4,933,269